Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B

Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.

Read the full article » | Posted 08-16-2024

Related Articles